Novo Integrated Sciences Inc

NASDAQ:NVOS

Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 113 full-time employees. The company went IPO on 2005-07-12. The company owns Canadian and United States subsidiaries, which provide solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, personalized product offerings, and rehabilitative science. Its Canadian subsidiary, Novo Healthnet Limited, provides its services and products through both clinic and eldercare related operations. The company has two segments: healthcare services, and product manufacturing and development. Its primary care services include physiotherapy, chiropractic care, occupational therapy, eldercare, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury, kinesiology, vestibular therapy, and others. The company also provides global consulting specialized in providing value-added services for pharmaceutical, biotech, healthcare, hospital, medical, others.